Proteomics analysis of rat brain protein modulations by grape seed extract

Journal of Agricultural and Food Chemistry

Volumn 52, Issue 26, 2004, Pages 7872-7883

  Deshane, Jessy ^a,c   Chaves, Lisa ^c   Sarikonda, Kiran Varma ^a   Isbell, Scott ^a   Wilson, Landon ^a   Kirk, Marion ^a   Grubbs, Clinton ^a,b   Barnes, Stephen ^a,c   Meleth, Sreelatha ^a   Kim, Helen ^a,c,d  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b Kentucky   (United States)

^c PURDUE UNIVERSITY   (United States)

^d University of Alabama at Birmingham   (United States)

Author keywords

2D electrophoresis; Dementia; Dietary supplement; Grape polyphenols; Mass spectrometry

Indexed keywords

ALMAGATE; ANTIOXIDANT; BRAIN PROTEIN; GRAPE SEED EXTRACT; PLANT EXTRACT; PROANTHOCYANIDIN; PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGING; ALZHEIMER DISEASE; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN; BRAIN HOMOGENATE; DEMENTIA; DIET; DIET SUPPLEMENTATION; ELECTROPHORESIS; FEMALE; GRAPE; HEALTH; HOMOGENATE; INFLAMMATION; MAMMAL; MASS SPECTROMETRY; MODEL; MODULATION; MOUSE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PLANT SEED; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEOMICS; RAT; SEED; TISSUE; TWO DIMENSIONAL ELECTROPHORESIS;

ANIMALIA; MAMMALIA; VITIS SP.;

EID: 19944428309     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf040407d     Document Type: Article

References (60)

1. Fontanarosa, P. B.; Rennie, D.; DeAngelis, C. D. The need for regulation of dietary supplements - lessons from ephedra. JAMA - J. Am. Med. Assoc. 2003, 289, 1568-1570.
2. Yamakoshi, J.; Kataoka, S.; Koga, T.; Ariga, T. Proanthocyanidin-rich extract from grape seeds attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits. Atherosclerosis 1999, 142, 139-149.
3. Pataki, T.; Bak, I.; Kovacs, P.; Bagchi, D.; Das, D. K.; Tosaki, A. Grape seed proanthocyanidins improved cardiac recovery during reperfusion after ischemia in isolated rat hearts. Am. J. Clin. Nutr. 2002, 75, 894-899.
4. Bagchi, D.; Sen, C. K.; Ray, S. D.; Das, D. K.; Bagchi, M.; Preuss, H. G.; Vinson, J. A. Molecular mechanisms of cardioprotection by a novel grape seed proanthocyanidin extract. Mutat. Res. 2003, 523-524, 87-97.
5. Bagchi, D.; Bagchi, M.; Stohs, S.; Ray, S. D.; Sen, C. K.; Preuss, H. G. Cellular protection with proanthocyanidins derived from grape seeds. Ann. N. Y. Acad. Sci. 2002, 957, 260-270.
6. Joseph, J. A.; Shukitt-Hale, B.; Denisova, N. A.; Bielinski, D.; Martin, A.; McEwen, J. J.; Bickford, P. C. Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J. Neurosci. 1999, 19, 8114-8121.
7. Bastianetto, S.; Quirion, R. Natural extracts as possible protective agents of brain aging. Cell. Mol. Biol. 2002, 48, 693-697.
8. Chandrasekaran, K.; Mehrabian, Z.; Spinnewyn, B.; Chinopoulos, C.; Drieu, K.; Fiskum, G. Bilobalide, a component of the Ginkgo biloba extract (EGb 761), protects against neuronal death in global brain ischemia and in glutamate-induced excitotoxicity. Cell. Mol. Biol. 2002, 48, 663-669.
9. Kim, H.; Xia, H.; Li, L.; Gewin, J. Attenuation of neurodegeneration- relevant modifications of brain proteins by dietary soy. Biofactors 2000, 12, 243-250.
10. Pan, Y.; Anthony, M.; Watson, S.; Clarkson, T. B. Soy phytoestrogens improve radial arm maze performance in ovariectomized retired breeder rats and do not attenuate benefits of 17β-estradiol treatment. Menopause 2000, 7, 230-235.
11. Yamakoshi, J.; Saito, M.; Kataoka, S.; Kikuchi, M. Safety evaluation of proanthocyanidin-rich extract from grape seeds. Food Chem. Toxicol. 2002, 40, 599-607.
12. Gibbons, J. D. In Nonparametric Methods of Quantitative Analysis; American Science Press: Columbus, OH, 1997; Chapter 4, pp 169-212.
13. Mardia, K. V.; Kent, J. T.; Bibby, J. M. In Multivariate Analysis; TJ Press (Padstow): Cornwall, U.K., 1995; Chapter 11, pp 301-324.
14. Mardia, K. V.; Kent, J. T.; Bibby, J. M. In Multivariate Analysis; TJ Press (Padstow): Cornwall, U.K., 1995; Chapter 8, pp 213-246.
15. Tuma, R.; Coward, L. U.; Kirk, M. C.; Barnes, S.; Prevelige, P. E., Jr. Hydrogen-deuterium exchange as a probe of folding and assembly in viral capsids. J. Mol. Biol. 2001, 23, 389-396.
16. Pappin, D. J. C.; Hojrup, P.; Bleasby, A. J. Rapid identification of proteins by peptide-mass fingerprinting. Protein Sci. 1993, 3, 327-332.
17. Bleasby, A. J.; Wootton, J. C. Construction of validated, non-redundant composite protein sequence databases. Protein Eng. 1990, 3, 153-159.
18. Carninci, P.; Hayashizaki, Y. High-efficiency full-length cDNA cloning. Methods Enzymol. 1999, 303, 19-44.
19. Schonberger, S. J.; Edgar, P. F.; Kydd, R.; Faull, R. L. M.; Cooper, G. J. S. Proteomic analysis of the brain in Alzheimer's disease: Molecular phenotype of a complex disease process. Proteomics 2001, 1, 1519-1528.
20. Tsuji, T.; Shiozaki, A.; Kohno, R.; Yoshizato, K.; Shimohama, S. Proteomic profiling and neurodegeneration in Alzheimer's disease. Neurochem. Res. 2002, 27, 1245-1253.
21. Tilleman, K.; Stevens, I.; Spittaels, K.; Haute, C. V.; Clerens, S.; Van Den Bergh, G.; Geerts, H.; Van Leuven, F.; Vandesande, F.; Moens, L. Differential expression of brain proteins in glycogen synthase kinase-3 transgenic mice: a proteomics point of view. Proteomics 2002, 2, 94-104.
22. Tilleman, K.; Van den Haute, C.; Geerts, H.; van Leuven, F.; Esmans, E. L.; Moens, L. Proteomics analysis of the neurodegeneration in the brain of tau transgenic mice. Proteomics 2002, 2, 656-665.
23. Spittaels, K.; Van den Haute, C.; Van Dorpe, J.; Geerts, H.; Mercken, M.; Bruynseels, K.; Lasrado, R.; Vandezande, K.; Laenen, I.; Boon, T.; Van Lint, J.; Vandenheede, J.; Moechars, D.; Loos, R.; Van Leuven, F. Glycogen synthase kinase-3β phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice. J. Biol. Chem. 2000, 275, 41340-41349.
24. Spittaels, K.; Van den Haute, C.; Van Dorpe, J.; Bruynseels, K.; Vandezande, K.; Laenen, I.; Geerts, H.; Mercken, M.; Sciot, R.; Van Lommel, A.; Loos, R.; Van Leuven, F. Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. Am. J. Pathol. 1999, 155, 2153-2165.
25. Hirschi, K. D.; Kreps, J. A.; Hirschi, K. K. Molecular approaches to studying nutrient metabolism and function: an array of possibilities. J. Nutr. 2001, 131, 1605S-1609S.
26. Muller, M.; Kersten, S. Nutrigenomics: goals and strategies. Nat. Rev. Genet. 2003, 4, 315-322.
27. Ideker, T.; Thorsson, V.; Ranish, J. A.; Christmas, R.; Buhler, J.; Eng, J. K.; Bumgarner, R.; Goodlett, D. R.; Aebersold, R.; Hood, L. Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. Science 2001, 292, 929-934.
28. Washburn, M. P.; Ulaszek, R.; Deciu, C.; Schieltz, D. M.; Yates, J. R., 3rd. Analysis of quantitative proteomic data generated via multidimensional protein identification technology. Anal. Chem. 2002, 74, 1650-1657.
29. Xiong, M.; Jin, L.; Li, W.; Boerwinkle, E. Computational methods for gene expression-based tumor classification. Biotechniques 2000, 29, 1264-1268.
30. Mendez, M. A.; Hodar, C.; Vulpe, C.; Gonzalez, M.; Cambiazo, V. Discriminant analysis to evaluate clustering of gene expression data. FEBS Lett. 2002, 522, 24-28.
31. Liu, A.; Zhang, Y.; Gehan, E.; Clarke, R. Block principal component analysis with application to gene microarray data classification. Statist. Med. 2002, 21, 3465-3474.
32. Quackenbush, J. Microarray data normalization and transformation. Nat. Genet. 2002, 32, 496-501.
33. Wise, M. J.; Littlejohn, T. G.; Humphery-Smith, I. Peptide-mass fingerprinting and the ideal covering set for protein characterization. Electrophoresis 1997, 18, 1399-1409.
34. 2+-binding and antiapoptotic properties is a novel proteolytic target of calpain during etoposide-induced apoptosis. J. Biol. Chem. 1999, 274, 28476-28483.
35. Mosser, D. D.; Caron, A. W.; Bourget, L.; Meriin, A. B.; Sherman, M. Y.; Morimoto, R. I.; Massie, B. The chaperone function of hsp70 is required for protection against stress-induced apoptosis. Mol. Cell. Biol. 2000, 20, 7146-7159.
36. Friedman, D. L.; Roberts, R. Compartment of brain-type creatine kinase and ubiquitous mitochondrial creatine kinase in neurons: evidence for a creatine phosphate energy shuttle in adult rat brain. J. Comput. Neurol. 1994, 343, 500-511.
37. Wallimann, T.; Wyss, M.; Brdiczka, D.; Nicolay, K.; Eppenberger, H. M. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis. Biochem. J. 1992, 281, 21-40.
38. Bajo, M.; Yoo, B. C.; Cairns, N.; Gratzer, M.; Lubec, G. Neurofilament proteins NF-L, NF-M and NF-H in brain of patients with Down syndrome and Alzheimer's disease. Amino Acids 2001, 21, 293-301.
39. Oblinger, M. M.; Singh, L. D. Reactive astrocytes in neonate brain upregulate intermediate filament gene expression in response to axonal injury. Int. J. Dev. Neurosci. 1993, 11, 149-156.
40. Kawai, J., et al. Functional annotation of a full-length mouse cDNA collection. Nature 2001, 409, 685-690.
41. Messier, C.; Gagnon, M. Glucose regulation and cognitive functions: relation to Alzheimer's disease and diabetes. Behav. Brain Res. 1996, 75, 1-11.
42. Fountoulakis, M.; Juranville, J. F.; Dierssen, M.; Lubec, G. Proteomic analysis of the fetal brain. Proteomics 2002, 2, 1547-1576.
43. Chen, W.; Ji, J.; Xu, X.; He, S.; Ru, B. Proteomic comparison between human young and old brains by two-dimensional gel electrophoresis and identification of proteins. Int. J. Dev. Neurosci. 2003, 21, 209-216.
44. Cheon, M. S.; Fountoulakis, M.; Dierssen, M.; Ferreres, J. C.; Lubec, G. Expression profiles of proteins in fetal brain with Down syndrome. J. Neural Transmission, Suppl. 2001, 61, 311-319.
45. Krapfenbauer, K.; Engidawork, E.; Cairns, N.; Fountoulakis, M.; Lubec, G. Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders. Brain Res. 2003, 967, 152-160.
46. Krapfenbauer, K.; Berger, M.; Lubec, G.; Fountoulakis, M. Changes in the brain protein levels following administration of kainic acid. Electrophoresis 2001, 22, 2086-2091.
47. Krapfenbauer, K.; Berger, M.; Friedlein, A.; Lubec, G.; Fountoulakis, M. Changes in the levels of low-abundance brain proteins induced by kainic acid. Eur. J. Biochem. 2001, 268, 3532-3537.
48. Korolainen, M. A.; Goldsteins, G.; Alafuzoff, I.; Koistinaho, J.; Pirttila, T. Proteomic analysis of protein oxidation in Alzheimer's disease brain. Electrophoresis 2002, 23, 3428-3433.
49. Castegna, A.; Aksenov, M.; Thongboonkerd, V.; Klein, J. B.; Pierce, W. M.; Booze, R.; Markesbery, W. R.; Butterfield, D. A. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, α-enolase and heat shock cognate 71. J. Neurochem. 2002, 82, 1524-1532.
50. Stackman, R. W.; Eckenstein, F.; Frei, B.; Kulhanek, D.; Nowlin, J.; Quinn, J. F. Prevention of age-related spatial memorydeficits in a transgenic mouse model of Alzheimer's disease by chronic Ginkgo biloba treatment. Exp. Neurol. 2003, 184, 510-520.
51. Ercoli, L.; Small, G. W.; Silverman, D. H. S.; Sidarth, P.; Dorsey, D.; Miller, K.; Kaplan, A.; Skura, S.; Byrd, G.; Huang, S. C.; Phelps, M. E. The effects of Ginkgo biloba on cognitive and cerebral metabolic function in age-associated memory impairment. Presented at the 34th Annual Meeting of the Society for Neuroscience, 2003.
52. van Dongen, M.; van Rossum, E.; Kessels, A.; Sielhorst, H.; Knipschild, P. Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial. J. Clin. Epidemiol. 2003, 56, 367-376.
53. Watanabe, C. M.; Wolffram, S.; Ader, P.; Rimbach, G.; Packer, L.; Maguire, J. J.; Schultz, P. G.; Gohil, K. The in vivo neuromodulatory effects of the herbal medicine Ginkgo biloba. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 6577-6580.
54. Truelsen, T.; Thudium, D.; Gronbaek, M. Amount and type of alcohol and risk of dementia: the Copenhagen City Heart Study. Neurology 2002, 59, 1313-1319.
55. Shumaker, S. A.; Legault, C.; Rapp, S. R.; Thal, L.; Wallace, R. B.; Ockene, J. K.; Hendrix, S. L.; Jones, B. N., 3rd; Assaf, A. R.; Jackson, R. D.; Kotchen, J. M.; Wassertheil-Smoller, S.; Wactawski-Wende, J.; WHIMS Investigators. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA - J. Am. Med. Assoc. 2003, 289, 2651-2662.
56. Aksenova, M. V.; Aksenov, M. Y.; Payne, R. M.; Trojanowski, J. Q.; Schmidt, M. L.; Carney, J. M.; Butterfield, D. A.; Markesbery, W. R. Oxidation of cytosolic proteins and expression of creatine kinase BB in frontal lobe in different neurodegenerative disorders. Dement. Geriatr. Cogn. Disord. 1999, 10, 158-165.
57. Aksenov, M.; Aksenova, M.; Butterfield, D. A.; Markesbery, W. R. Oxidative modification of creatine kinase BB in Alzheimer's disease brain. J. Neurochem. 2000, 74, 2520-2527.
58. Aksenov, M. Y.; Aksenova, M. V.; Butterfield, D. A.; Geddes, J. W.; Markesbery, W. R. Protein oxidation in the brain in Alzheimer's disease. Neuroscience 2001, 103, 373-383.
59. Xie, D. Y.; Sharma, S. B.; Paiva, N. L.; Ferreira, D.; Dixon, R. A. Role of anthocyanidin reductase, encoded by BANYULS in plant flavonoid biosynthesis. Science 2003, 299, 396-399.
60. Kim, H.; Hall, P.; Smith, M.; Kirk, M.; Prasin, J. K.; Barnes, S.; Grubbs, C. Chemoprevention by grape seed extract and genistein in carcinogen-induced mammary cancer in rats is diet dependent. J. Nutr. 2004, 134, 3445S-3452S.